Opportunity Information: Apply for 72067522APS00002
The Guinea Local Health System Strengthening (GLHSS) opportunity is an umbrella Annual Program Statement (APS) issued by the U.S. Agency for International Development (USAID) Mission in Guinea to support a five-year effort aimed at improving the performance of local health systems in targeted areas of Guinea. The central idea is to help ensure that people can access higher-quality health care closer to where they live, particularly through community-level services and local public health facilities. Rather than focusing on a single narrow intervention, GLHSS is framed as a broader platform for strengthening how local health services are organized, managed, and delivered so that routine care and public health functions work better at the community and facility levels.
The activity was designed through a collaborative process involving USAID/Guinea, USAID/Washington, Guinea's Ministry of Health (MOH), and other stakeholders in the health sector. That co-design approach is intended to continue throughout implementation, meaning priorities, technical focus areas, and specific health topics can be refined as lessons emerge and as additional information gaps are identified. In practical terms, the APS sets the overall goal, purpose, expected results, and programming priorities for GLHSS, while leaving room for USAID to fund multiple related awards over time as needs and opportunities become clearer.
This funding opportunity is categorized as discretionary and anticipates using a Cooperative Agreement as the primary funding instrument. A Cooperative Agreement typically signals substantial involvement by USAID during implementation, which aligns with the described co-engagement model with government and sector partners. The activity category is Health, and the listing is associated with CFDA 98.001. Eligible applicants are listed as unrestricted, indicating that a wide range of organizations may be able to compete, subject to standard USAID requirements and any specific eligibility conditions laid out in future rounds.
A key detail is that this particular APS notice is not itself asking organizations to submit concept papers or full applications. It functions as the umbrella framework under which USAID may later run one or more APS "Rounds" that will actually solicit and compete concept papers and, potentially, full applications. When those rounds are issued, prospective applicants will be given a fair opportunity to submit competitive ideas for possible funding. In other words, organizations should treat this as an advance notice and strategic framework: it describes what USAID intends to achieve with GLHSS and how the program will be structured, but the actionable competitions will come later through subsequent round-specific solicitations.
From the published opportunity metadata, the funding opportunity title is "Guinea Local Health System Strengthening (GLHSS)," with opportunity number 72067522APS00002, managed by USAID Guinea (USAID-Conakry). The posting date is February 16, 2022, and the original closing date is listed as February 25, 2025. The award ceiling is shown as 0 and the expected number of awards is not specified in the provided data, which is consistent with an umbrella APS approach where amounts and award counts may be determined later, round by round. Overall, GLHSS is best understood as USAID/Guinea's multi-year mechanism to channel future competitions and cooperative agreements focused on strengthening local health system capacity and improving the quality and accessibility of care in selected geographic areas.Apply for 72067522APS00002
- The Guinea USAID-Conakry in the health sector is offering a public funding opportunity titled "Guinea Local Health System Strengthening (GLHSS)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2022-02-16.
- Applicants must submit their applications by 2025-02-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs) - Guinea Local Health System Strengthening (GLHSS)
1. What is the Guinea Local Health System Strengthening (GLHSS) opportunity?
GLHSS is an umbrella Annual Program Statement (APS) issued by the U.S. Agency for International Development (USAID) Mission in Guinea. It supports a five-year effort to improve the performance of local health systems in targeted areas of Guinea, with an emphasis on helping people access higher-quality health care closer to where they live.
2. What is the main goal of GLHSS?
The main goal is to strengthen how local health services are organized, managed, and delivered so that routine health care and public health functions work better at the community and local facility levels.
3. What types of health services or levels of the system does GLHSS focus on?
GLHSS focuses particularly on community-level services and local public health facilities. The intent is to improve quality and accessibility of care near where people live.
4. Is GLHSS focused on one specific disease or a single intervention?
No. GLHSS is framed as a broader platform for local health system strengthening rather than a single narrow intervention. It is designed to improve performance and delivery across community and facility levels.
5. Who designed the GLHSS activity?
The activity was designed through a collaborative process involving USAID/Guinea, USAID/Washington, Guinea's Ministry of Health (MOH), and other stakeholders in the health sector.
6. Will priorities or technical focus areas stay fixed throughout implementation?
Not necessarily. The opportunity describes a co-design and co-engagement approach intended to continue during implementation. Priorities, technical focus areas, and specific health topics may be refined as lessons emerge and as information gaps are identified.
7. What does it mean that GLHSS is an "umbrella" APS?
It means the APS provides an overall framework (goal, purpose, expected results, and programming priorities), while allowing USAID to fund multiple related awards over time. Specific opportunities to submit and compete proposals are expected to come later through APS "Rounds."
8. Does this APS notice request concept papers or full applications right now?
No. This APS notice is not asking organizations to submit concept papers or full applications. It serves as an advance notice and strategic framework. Future APS rounds are expected to provide the actual solicitations for concept papers and possibly full applications.
9. How will organizations be able to compete for GLHSS funding?
USAID may later issue one or more APS rounds under this umbrella APS. When rounds are issued, prospective applicants are expected to be given a fair opportunity to submit competitive ideas for potential funding.
10. What funding instrument is anticipated for GLHSS awards?
The opportunity anticipates using a Cooperative Agreement as the primary funding instrument.
11. What does a Cooperative Agreement imply for implementation?
A Cooperative Agreement typically indicates substantial involvement by USAID during implementation. This aligns with the described co-engagement model with government and sector partners.
12. What is the funding opportunity category for GLHSS?
The activity category is Health.
13. What is the CFDA listing associated with this opportunity?
The listing is associated with CFDA 98.001.
14. Who is managing this opportunity?
The opportunity is managed by USAID Guinea (USAID-Conakry).
15. What is the official opportunity title and number?
The official title is "Guinea Local Health System Strengthening (GLHSS)" and the opportunity number is 72067522APS00002.
16. When was this APS posted?
The posting date is February 16, 2022.
17. What is the listed closing date for this APS?
The original closing date is listed as February 25, 2025.
18. What is the award ceiling for this opportunity?
The award ceiling is shown as 0 in the published opportunity metadata, which is consistent with an umbrella APS approach where specific funding levels may be determined later, round by round.
19. How many awards does USAID expect to make under GLHSS?
The expected number of awards is not specified in the provided data. This fits the umbrella APS approach, where awards and counts may be determined later through separate rounds.
20. Who is eligible to apply?
Eligible applicants are listed as unrestricted, indicating that a wide range of organizations may be able to compete, subject to standard USAID requirements and any specific eligibility conditions included in future round announcements.
21. What geographic areas does GLHSS target?
The opportunity states that GLHSS focuses on targeted areas of Guinea, but the specific locations are not provided in the information available here.
22. What should organizations do now if they are interested in GLHSS?
Based on the information provided, organizations should treat this APS as an advance notice and strategic framework and watch for future APS rounds that will solicit concept papers and potentially full applications.
Browse more opportunities from the same category: Health
Next opportunity: Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
Previous opportunity: OVW Fiscal Year 2022 Grants to Tribal Governments to Exercise Special Domestic Violence Criminal Jurisdiction Solicitation
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72067522APS00002
Applicants also applied for:
Applicants who have applied for this opportunity (72067522APS00002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional) Apply for RFA RM 22 001 Funding Number: RFA RM 22 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) Apply for RFA RM 22 008 Funding Number: RFA RM 22 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 23 005 Funding Number: RFA AG 23 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 014 Funding Number: RFA AG 23 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) Apply for PAR 22 000 Funding Number: PAR 22 000 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21) Apply for RFA HL 23 018 Funding Number: RFA HL 23 018 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 22 089 Funding Number: PAR 22 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) Apply for RFA AG 23 007 Funding Number: RFA AG 23 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 22 011 Funding Number: RFA RM 22 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 22 009 Funding Number: RFA RM 22 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed) Apply for RFA RM 22 010 Funding Number: RFA RM 22 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed) Apply for RFA AI 22 012 Funding Number: RFA AI 22 012 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) Apply for RFA RM 22 013 Funding Number: RFA RM 22 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 22 012 Funding Number: RFA RM 22 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 015 Funding Number: RFA AG 23 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 012 Funding Number: RFA AG 23 012 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 013 Funding Number: RFA AG 23 013 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 010 Funding Number: RFA AG 23 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) Apply for RFA AG 23 011 Funding Number: RFA AG 23 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 22 128 Funding Number: PAR 22 128 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72067522APS00002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.